Electromed, Inc.
AMEX:ELMDMedical - Devices
Healthcare
$23.26 +1.16%
+$0.43 today
- Market cap
- $190.13M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
52W Low $17.73High $40.00
Volume 0.05M
Average 0.06M
Income Statement
Follow revenue through to earnings.
Revenue
$64.00M
FY 2025 · Annual
+17.0% YoYOperating Income
$9.87M
FY 2025 · Annual
+50.0% YoYNet Income
$7.54M
FY 2025 · Annual
+46.3% YoYIncome Statement
USD
Metric | FY 2021 Jun 2021 | FY 2022 Jun 2022 | FY 2023 Jun 2023 | FY 2024 Jun 2024 | FY 2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 35.76M | 41.66M | 48.07M | 54.72M | 64M |
| Cost of Revenue | 8.45M | 10.22M | 11.55M | 12.99M | 14.03M |
| Gross Profit | 27.31M | 31.44M | 36.52M | 41.73M | 49.97M |
| Gross Margin | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% |
| Research & Development | 1.72M | 1.36M | 916K | 656K | 996K |
| Selling, General & Admin | 22.44M | 27.11M | 31.6M | 34.49M | 39.1M |
| Operating Expenses | 24.17M | 28.47M | 32.51M | 35.15M | 40.1M |
| Depreciation & Amortization | 610K | 628K | 613K | 841K | 1.17M |
| EBITDA | 3.78M | 3.63M | 4.7M | 7.88M | 11.46M |
| EBITDA Margin | 10.6% | 8.7% | 9.8% | 14.4% | 17.9% |
| Operating Income | 3.14M | 2.97M | 4.01M | 6.58M | 9.87M |
| Operating Margin | 8.8% | 7.1% | 8.3% | 12.0% | 15.4% |
| Interest Income | 39K | 25K | 78K | 455K | 624K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 27K | 25K | 78K | 455K | 412K |
| Income Before Tax | 3.17M | 3M | 4.09M | 7.04M | 10.28M |
| Pre-Tax Margin | 8.9% | 7.2% | 8.5% | 12.9% | 16.1% |
| Income Tax Expense | 805K | 692K | 920K | 1.89M | 2.75M |
| Net Income | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M |
| Net Margin | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% |
| EPS (Basic) | 0.28 | 0.27 | 0.37 | 0.60 | 0.90 |
| EPS (Diluted) | 0.27 | 0.26 | 0.36 | 0.58 | 0.86 |
| 8.57M | 8.47M | 8.46M | 8.56M | 8.33M | |
| 8.91M | 8.77M | 8.7M | 8.86M | 8.72M |
ELMD Earnings Waterfall · TTM
AMEX:ELMD · Revenue to Net Income
Key Ratios
EPS$1.17
Gross Margin78.4%
Net Margin14.0%
P/E Ratio20.6
P/S Ratio11.4
Analysis
$71.8M of revenue converted into $10.1M of net income for the selected period. Gross margin is 78.4% and net margin is 14.0%, showing how much revenue survives after costs and taxes. EPS is $1.17, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| DEF 14A | DEF 14A filing | Sep 29, 2026 | |
| ARS | ARS filing | Sep 29, 2026 | |
| DEFA14A | DEFA14A filing | Sep 29, 2026 |
How much revenue does ELMD generate?
Electromed, Inc. (ELMD) reported $64.00M of revenue in fiscal 2025.
Is ELMD profitable?
Electromed, Inc. (ELMD) reported $7.54M of net income, with a net margin of 11.8%.
Continue the stock analysis
Jump to another research area for this company.